Cancer

The latest cancer news from UNC Health Care and the UNC School of Medicine.

Lamberth and Shirley Mitchell:  Losing Teeth, but Keeping Spirit and Faith

Lamberth and Shirley Mitchell: Losing Teeth, but Keeping Spirit and Faith

A 65-year-old Person County man is successfully treated for a rare head and neck cancer, but the treatment side effects damaged his teeth and gums. He may have lost his pearly whites, but not his spirit or his faith.

Lamberth and Shirley Mitchell: Losing Teeth, but Keeping Spirit and Faith - Read More…

Factors influencing delay in breast cancer treatment differ for African-American and white women

Scientists found that among white women, household size and losing a job due to one's diagnosis were reasons for delay in treatment, while among African-American women, the type of treatment received influenced delay.

Factors influencing delay in breast cancer treatment differ for African-American and white women - Read More…

Outdated practice of annual cervical cancer screenings may cause more harm than good

About half of the obstetrician-gynecologists surveyed in a recent study said they continue to provide annual exams. Drs. Russell Harris and Stacey Sheridan of UNC say this is an outdated practice that may be more harmful than helpful.

Outdated practice of annual cervical cancer screenings may cause more harm than good - Read More…

Inhibiting macrophage MerTK signaling creates an innate immune response against cancer

Inhibiting macrophage MerTK signaling creates an innate immune response against cancer

New evidence by a UNC-led team shows that MerTK macrophage action in the microenvironment that surrounds cancer cells blunts the immune response, allowing the tumor cell to grow and metastasize.

Inhibiting macrophage MerTK signaling creates an innate immune response against cancer - Read More…

UNC murine study predicts cancer drug responsiveness in human tumors

UNC murine study predicts cancer drug responsiveness in human tumors

A UNC research team found that genetically engineered mouse models (GEMMs) were able to accurately predict human response to a standard chemotherapy drug combination commonly used in the clinic.

UNC murine study predicts cancer drug responsiveness in human tumors - Read More…

Cancer drug labels missing key information about patients’ symptoms

Cancer drug labels missing key information about patients’ symptoms

Dr. Ethan Basch of UNC calls for pharmaceutical manufacturers to collect rigorous information on how drugs impact symptoms and quality of life starting early in drug development, and for the U.S. Food and Drug Administration (FDA) to include this information in drug labels.

Cancer drug labels missing key information about patients’ symptoms - Read More…

Human and canine lymphomas share molecular similarities, first large-scale comparison shows

Human and canine lymphomas share molecular similarities, first large-scale comparison shows

A team of scientists from the University of North Carolina School of Medicine, North Carolina State University’s College of Veterinary Medicine and Duke University have conducted one of the first studies to directly compare canine and human B-cell lymphoma by examining molecular similarities and differences between the two species.

Human and canine lymphomas share molecular similarities, first large-scale comparison shows - Read More…

 Researchers identify key player in the genesis of human intestinal immunity

Researchers identify key player in the genesis of human intestinal immunity

Better treatments for people suffering from compromised intestinal immunity may emerge from a small-animal model of human intestinal immune development.

Researchers identify key player in the genesis of human intestinal immunity - Read More…

Kathy DeClue: A Second Chance to Say ‘I Do’

Kathy DeClue: A Second Chance to Say ‘I Do’

Kathy DeClue of Randolph County was featured in Family House Diaries in August 2012. She celebrated the success of a second stem cell transplant for leukemia by renewing her wedding vows with her husband of 41 years before 80 friends and family.

Kathy DeClue: A Second Chance to Say ‘I Do’ - Read More…

UNC genetics researcher helps open Smithsonian exhibit

UNC genetics researcher helps open Smithsonian exhibit

Clinical geneticist James Evans, MD, PhD helped to open the exhibition, Genome: Unlocking Life's Code. The high-tech, high-intensity display celebrates the 10th anniversary of production of the first complete human genome sequence also known as the genetic blueprint of the human body.

UNC genetics researcher helps open Smithsonian exhibit - Read More…

Eligibility for aspirin for primary prevention in men increases when cancer mortality benefit added

Eligibility for aspirin for primary prevention in men increases when cancer mortality benefit added

A research team, including UNC scientists, reports that including the positive effect of aspirin on cancer mortality influences the threshold for prescribing aspirin for primary prevention in men.

Eligibility for aspirin for primary prevention in men increases when cancer mortality benefit added - Read More…

UNC to test interventions aimed at reducing colon cancer screening disparities

UNC to test interventions aimed at reducing colon cancer screening disparities

The study will focus on assessing the impact of a clinic-based intervention that includes having patients view a multimedia decision aid (in English or Spanish) before seeing their physician, as well as support from a bilingual patient “navigator” on completion of recommended colon cancer screening tests.

UNC to test interventions aimed at reducing colon cancer screening disparities - Read More…

 UNC researchers identify another piece of the “histone code” puzzle

UNC researchers identify another piece of the “histone code” puzzle

New research from the UNC School of Medicine has shown how a protein called UHRF1 “reads” the histone code in a specific way to perform an important cellular function.

UNC researchers identify another piece of the “histone code” puzzle - Read More…

The value of randomized clinical trials in radiation oncology clinical practice

The value of randomized clinical trials in radiation oncology clinical practice

Are there enough clinical trials data to guide every radiation oncology decision in a cancer patient's care? Not necessarily, according to a UNC School of Medicine study.

The value of randomized clinical trials in radiation oncology clinical practice - Read More…

UNC scientists identify possible KRAS downstream target for pancreatic cancer therapy

UNC scientists identify possible KRAS downstream target for pancreatic cancer therapy

A University of North Carolina School of Medicine team offers first evidence of the role of a protein called GSK-3 alpha in promoting oncogenic KRAS function.

UNC scientists identify possible KRAS downstream target for pancreatic cancer therapy - Read More…

IMRT may not be more effective than older radiation techniques after prostatectomy

IMRT may not be more effective than older radiation techniques after prostatectomy

Intensity-modulated radiation therapy has become the most commonly used type of radiation in prostate cancer, but research from UNC suggests that the therapy may not be more effective than older, less expensive forms of radiation therapy in patients who have had a prostatectomy.

IMRT may not be more effective than older radiation techniques after prostatectomy - Read More…

John Burnett:  Kindness Rules the Day

John Burnett: Kindness Rules the Day

An Ashe County man witnesses random acts of kindness daily – both as a deliberate and often anonymous giver and as an ever-grateful receiver – while in Chapel Hill for the treatment of non-Hodgkin lymphoma.

John Burnett: Kindness Rules the Day - Read More…

Novel monoclonal antibody inhibits tumor growth in breast cancer and angiosarcoma

Novel monoclonal antibody inhibits tumor growth in breast cancer and angiosarcoma

The antibody, created at the University of North Carolina, is the first therapeutic discovered that targets a protein known as SFRP2.

Novel monoclonal antibody inhibits tumor growth in breast cancer and angiosarcoma - Read More…

Transcription factors regulating blood oxygen linked to melanoma metastases

Transcription factors regulating blood oxygen linked to melanoma metastases

Researchers at the University of North Carolina have discovered that transcription factors regulating the levels of oxygen in the blood also play a role in the spread of the skin cancer melanoma.

Transcription factors regulating blood oxygen linked to melanoma metastases - Read More…

Claudia Laskow:  A Sense of Humor Carries the Day

Claudia Laskow: A Sense of Humor Carries the Day

A Dare County real estate agent refuses to let a breast cancer diagnosis and its treatment detract from her trademark sense of humor and constant outreach to others.

Claudia Laskow: A Sense of Humor Carries the Day - Read More…

Share This: